Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer

This study has been completed.

Study NCT00650910 Information provided by GlaxoSmithKline

First Received: March 28, 2008 Last Updated: August 18, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2009
Primary Completion Date:	July 2009 (Final data collection date for primary outcome measure)